首站-论文投稿智能助手
典型文献
The successful use of extracorporeal membrane oxygenation combined with continuous renal replacement therapy for a cardiac arrest patient with refractory hypokalemia and diabetic ketoacidosis
文献摘要:
Dear editor, Diabetic ketoacidosis (DKA) is a common clinically severe disease, with an incidence of 24.9/1,000 among diabetes patients, and approximately 180,000 people in the United States suffer from DKA every year.[1] The reported mortality rate associated with DKA ranges from 0.65% to 3.30%, and is commonly caused by electrolyte imbalances, especially hypokalemia and hyperkalemia.[2] Reports indicated that hypokalemia was observed in 5.6% of patients with DKA before therapy,[3] and the overall prevalence of hypokalemia during treatment for DKA was 38%.[4] Several studies have shown that hypokalemia can lead to fatal dysrhythmia and even cardiac arrest, which are positively associated with increased mortality.
文献关键词:
作者姓名:
Yang Li;Rui Xu;Chun-Shui Cao;Liang Huang
作者机构:
Department of Emergency Medicine,the First Affiliated Hospital of Nanchang University,Nanchang 330006,China
引用格式:
[1]Yang Li;Rui Xu;Chun-Shui Cao;Liang Huang-.The successful use of extracorporeal membrane oxygenation combined with continuous renal replacement therapy for a cardiac arrest patient with refractory hypokalemia and diabetic ketoacidosis)[J].世界急诊医学杂志(英文),2022(04):337-340
A类:
Diabetic,dysrhythmia
B类:
successful,extracorporeal,membrane,oxygenation,combined,continuous,renal,replacement,therapy,cardiac,arrest,refractory,hypokalemia,diabetic,ketoacidosis,Dear,editor,DKA,clinically,severe,disease,incidence,among,diabetes,patients,approximately,people,United,States,suffer,from,every,year,reported,mortality,rate,associated,ranges,commonly,caused,by,electrolyte,imbalances,especially,hyperkalemia,Reports,indicated,that,was,observed,before,overall,prevalence,during,treatment,Several,studies,have,shown,can,lead,fatal,even,which,are,positively,increased
AB值:
0.611957
相似文献
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Jia Lu;Ting Li;Zhichao Liao;Hui Yu;Yongtian Zhao;Haixiao Wu;Zhiwu Ren;Jun Zhao;Ruwei Xing;Sheng Teng;Yun Yang;Xiangchun Li;Kexin Chen;Jonathan Trent;Jilong Yang-Department of Bone and Soft Tissue Tumor,2Department of Infection Management,3Key Laboratory of Molecular Cancer Epidemiology,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;YuceBio Technology Co.,Ltd.,Shenzhen 518172,China;Department of Epidemiology and Biostatistics,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;Sarcoma Multidisciplinary Program,Sylvester Comprehensive Cancer Center,The University of Miami,Miami,FL 33136,USA
Prognostic role of plasma levels of γ-glutamyl transpeptidase in patients with advanced gastric cancer treated with anti-PD-1 immunotherapy
Shaojie Xu;Yiming Feng;Xingyin Li;Zaozao Huang;Hewei Li;Ganxin Wang-First Clinical College,Huazhong University of Science and Technology,Wuhan 430022,China;Department of Radiology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Yangchunhu Community Hospital,Liyuan Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430077,China;Department of Orthopedics,Liyuan Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430077,China;Cancer Center,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China
Quality metrics and outcomes among critically ill patients in China: results of the national clinical quality control indicators for critical care medicine survey 2015-2019
Rui Xi;Dong Fen;Ma Xudong;Su Longxiang;Shan Guangliang;Guo Yanhong;Long Yun;Liu Dawei;Zhou Xiang-Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100029, China;Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, China;Department of Medical Administration, National Health Commission of the People’s Republic of China, Beijing 100044, China;Department of Epidemiology and Biostatistics, Institute of Basic Medicine Sciences, Chinese Academy of Medical Sciences (CAMS) & School of Basic Medicine, Peking Union Medical College, Beijing 100005, China
Dynamic changes of renal cortical blood perfusion before and after percutaneous transluminal renal artery stenting in patients with severe atherosclerotic renal artery stenosis
Ma Na;Li Yan;Wang Siyu;Li Mengpu;Li Yongjun;Ai Hu;Zhu Hui;Wang Yang;Guo Fajin;Ren Junhong-Department of Sonography, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Vascular Surgery, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Cardiology, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Nuclear Medicine, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Medical Research & Biometrics Center, National Center for Cardiovascular Diseases and Fuwai Hospital, CAMS and PUMC, Beijing 100037, China
Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis
Liu Jiaye;Tian Ye;Fu Xia;Mu Chunyang;Yao Menglin;Ni Yinyun;Liu Yong;Li Zhihui-Department of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;Laboratory of Thyroid and Parathyroid Diseases, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610000, China;Respiratory Health Institute, Frontiers Science Center for Disease Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;Department of Ultrasound, West China Hospital of Sichuan University, Chengdu, Sichuan 610000, China;Department of Outpatients, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;Department of Liver Surgery and Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China;Department of Gastroenterological Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610000, China
Global prevalence, mortality, and main risk factors for COVID-19 associated pneumocystosis: A systematic review and meta-analysis
Hossein Khodadadi;Ehsan Ahmadpour;Sanam Nami;Rasoul Mohammadi;Hanieh Hosseini;Mahsa Behravan;Hamid Morovati-Department of Parasitology and Mycology,School of Medicine,Shiraz University of Medical Sciences,Shiraz,Iran;Drug Applied Research Center,Tabriz University of Medical Sciences,Tabriz,Iran;Department of Medical Mycology and Parasitology,School of Medicine,Tabriz University of Medical Sciences,Tabriz,Iran;Department of Medical Parasitology and Mycology,School of Medicine,Isfahan University of Medical Sciences,Isfahan,Iran;Immunology Research Center,Tabriz University of Medical Sciences,Tabriz,Iran;Student Research Committee,Shiraz University of Medical Sciences,Shiraz,Iran
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。